Home > Publications database > Novel devices and biomarkers in screening for esophageal squamous cell cancer > print

001     300639
005     20250602152123.0
024 7 _ |a 10.1016/j.bpg.2025.102005
|2 doi
024 7 _ |a 1521-6918
|2 ISSN
024 7 _ |a 1532-1916
|2 ISSN
024 7 _ |a altmetric:176113673
|2 altmetric
037 _ _ |a DKFZ-2025-00850
082 _ _ |a 610
100 1 _ |a Januszewicz, Wladyslaw
|0 0000-0002-8200-2661
|b 0
245 _ _ |a Novel devices and biomarkers in screening for esophageal squamous cell cancer
260 _ _ |a London [u.a.]
|c 2025
|b Harcourt
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1748870447_11243
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #LA:C150# / Volume 75, March 2025, 102005
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de
700 1 _ |a Nowicki-Osuch, Karol
|0 P:(DE-He78)5eecfbb3a55c32d69c08f67104c5c62b
|b 1
|e Last author
|u dkfz
773 _ _ |a 10.1016/j.bpg.2025.102005
|g p. 102005 -
|0 PERI:(DE-600)2028853-0
|p 102005
|t Best practice & research / Clinical gastroenterology
|v 75
|y 2025
|x 1521-6918
909 C O |p VDB
|o oai:inrepo02.dkfz.de:300639
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)5eecfbb3a55c32d69c08f67104c5c62b
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-17
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-17
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BEST PRACT RES CL GA : 2022
|d 2024-12-17
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2024-12-17
920 2 _ |0 I:(DE-He78)C150-20160331
|k C150
|l NWG Tumorgenese und molekulare Krebsprävention
|x 0
920 1 _ |0 I:(DE-He78)C150-20160331
|k C150
|l NWG Tumorgenese und molekulare Krebsprävention
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C150-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21